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Abstract Human complement component C8Q is an unusual
complement factor since it shows no homology to other
complement proteins but is a member of the lipocalin super-
family. So far, it has been found exclusively in plasma, covalently
linked to C8K by disulfide bridging. We have used dot blot and
Northern blot analyses of a large number of different human
tissues to survey systematically the expression pattern of C8Q.
Our experiments clearly showed that besides in liver, this gene is
also expressed in fetal and adult kidney. Renal expression of C8Q
is not dependent on C8K expression, since we could not detect
C8K expression in kidney. Thus its physiological function is not
restricted to a specific action in association with complement
components. As a prerequisite for further characterization of the
structure and binding activities of the uncomplexed C8Q, we have
expressed the encoding cDNA in Escherichia coli. To increase
the probability for proper folding of the characteristic intramo-
lecular disulfide bridge the recombinant protein was produced by
secretion to the periplasm.
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1. Introduction
Complement component C8, the penultimate member of
complement membrane attack complex (MAC), is composed
of three di¡erent polypeptides, K (Mr = 64 000 Da), L
(Mr = 64 000 Da) and Q (Mr = 22 000 Da) encoded by di¡erent
genes [1]. In plasma the C8 complex is arranged as a disul¢de-
linked C8K-Q dimer which is non-covalently associated with
C8L [2]. C8Q is structurally unrelated to any other complement
component but was found to be a member of the lipocalin
superfamily [3,4]. Members of this expanding family are small
mainly secretory proteins which are characterized by their
ability to bind or transport hydrophobic molecules and by
their common structure [5]. Within the highly divergent lip-
ocalin family C8Q shows signi¢cant amino acid sequence ho-
mology with K1-microglobulin and the closely related protein
HC (human complex-forming glycoprotein).
Whereas de¢ned roles in the formation and function of
MAC have been proposed for C8K and C8L [6], the function
of C8Q remains unclear. It is neither required for the synthesis
or function of C8, nor for the formation and lytic activity of
MAC [7]. Since retinol binding was reported for a number of
other lipocalins [8^10], it was suggested that C8Q might func-
tion as a retinol carrier. Previous studies indeed indicated a
weak binding of retinol and retinoic acid to C8K-Q [11]. How-
ever, this binding was not found in a more recent and reliable
study [7], thus a retinol carrier function remains doubtful.
Another postulated function of C8Q, namely to shield or oth-
erwise protect hydrophobic regions of C8K from premature
membrane interaction during biosynthesis processing, could
not be veri¢ed [7].
A major prerequisite for further investigations concerning
the biological function of C8Q is to know whether it is found
exclusively associated with complement components, or is ex-
pressed independently in other organs or tissues. Therefore we
have started investigations concerning the expression of C8Q
using PCR and Northern analysis. Since our studies have
clearly shown expression of C8Q in kidney independent of
C8K synthesis, we have expressed the C8Q encoding cDNA
from kidney in Escherichia coli. This uncomplexed form of
C8Q will be used in further studies concerning ligand binding
and structural analysis.
2. Materials and methods
2.1. RNA preparation
Total RNA from human liver and kidney was extracted by RNazol
B (Cinna/Biotecx) which is based on the method developed by
Chomczynski and Sacchi [12]. Poly(A) RNA was prepared using
oligo-dT cellulose. RNA was resuspended in diethylpyrocarbonate-
treated water and was examined on 1.2% agarose-formaldehyde gels.
2.2. Reverse transcription, RT-PCR analysis and molecular cloning
5 Wg of total RNA was reverse transcribed using 0.5 Wg of (dT)12ÿ18
as primer together with 200 units of Superscript II reverse transcrip-
tase, according to the manufacturer’s speci¢cations (Gibco BRL).
An aliquot (10%) of the cDNAs was ampli¢ed by PCR using the
primers E2C8QU: 5P-TTTGCAGGGACCTGGCTCCT-3P and
E2C8QL: 5P-AGCTTTCGGAAGGTACTGAC-3P corresponding to
nucleotides 200^219 and 317^336 of the C8Q cDNA [1] or primers
C8a 7-1: 5P-CACAAGAATCTTCACAAAGG-3P and C8a 7-2: 5P-
GTCAATCACCAGGATATATTC-3P for C8K [13]. PCR ampli¢ca-
tion was performed by the following reaction conditions (¢nal con-
centrations): 50 mM KCl, 10 mM Tris-HCl (pH 9.0), 0.01% gelatine,
0.1% Triton X-100, 3 mM MgCl2, 0.2 mM dNTPs, 30 pmol of pri-
mers in a total volume of 50 Wl. Each cycle entailed denaturation at
95‡C for 60 s, annealing at 55‡C for 60 s and primer extension at 72‡C
for 60 s. PCR products were analyzed on 2% agarose gels stained with
ethidium bromide. As a control the experiment was performed using
RNA without reverse transcription.
The resulting PCR fragment was puri¢ed by electrophoresis in a 2%
agarose gel and ligated into the pGEM-T vector (Promega Corp.,
USA) using the manufacturer’s protocol. The nucleotide sequence of
both strands of the double-stranded DNA was determined by cycle
sequencing using Taq polymerase [14].
2.3. Northern blot analysis
Total RNA isolated from human liver and kidney and commer-
cially available multiple tissue RNA blots (Clontech) were used for
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Northern blot analysis. Blots were hybridized for 18 h at 42‡C in ‘high
SDS’ solution: 7% SDS, 50% formamide, 5USSPE, 10% blocking
reagent (Boehringer, Germany), 0.1% lauroylsarcosine and 50 Wg/ml
salmon sperm DNA, with a 32P-labeled C8Q DNA probe. Blots were
washed for 2U15 min in 1USSC, 0.1% SDS at room temperature,
and for 2U15 min in 1USSC, 0.1% SDS at 55‡C.
2.4. Prokaryotic expression of the C8Q cDNA
For bacterial expression the region of the kidney-speci¢c C8Q
cDNA which encodes the mature protein was selectively ampli¢ed
by PCR using the primers C8gpQE-5: 5P-AAGCCTCAGAGGC-
CACGCCGGCCC-3P and PQEC8NG: 5P-CGCGGATCCCTCCT-
CACTTCGTCCAGG-3P. The latter primer incorporates sequences
for a unique BamHI site (Fig. 4). To achieve a 5P-blunt ended PCR
fragment we used PfuTurbo DNA Polymerase (Stratagene, USA).
The PCR product was digested with BamHI, puri¢ed by agarose gel
electrophoresis and ligated to a chemically synthesized DNA fragment
encoding the signal peptide sequence of E. coli OmpA. The OmpA
fragment contained a 5P-SphI cleavage site and a 3P-blunt end. After
ligation the OmpA-C8Q fusion was cloned into the SphI-BamHI site of
pQE-70 (Qiagen Inc., USA) and E. coli M15 [15] was used as a host.
At an OD600 of about 0.5, IPTG was added to a ¢nal concentration of
2 mM and the cells were grown for another 5 h. For puri¢cation of
the recombinant protein from periplasm, cells were centrifuged and
the pellet was resuspended in 1 M NaCl, 1 mM EDTA, 40 mM
sodium phosphate (pH 7.5) and kept on ice for 30 min [16]. The
spheroplasts formed during this step were separated by centrifugation
and the supernatant was dialyzed overnight against 1 mM NaCl, 40
mM sodium phosphate (pH 7.5) in order to remove the EDTA. The
resulting protein solution was directly applied to a⁄nity chromatog-
raphy on Ni-NTA resin (Qiagen Inc., USA) exactly as described by
the supplier and the recombinant protein was eluted by a gradient
of imidazole in column bu¡er. The eluted protein was characterized
by SDS-PAGE and N-terminal amino acid sequencing by a modi-
¢ed Edman degradation protocol on a gas/liquid phase sequenator
[17].
3. Results
3.1. Expression of C8Q in human kidney
To survey systematically the tissue-speci¢c expression of
C8Q, a Northern dot blot analysis was performed using a
commercially available RNA ¢lter on which poly(A)
RNAs from 50 di¡erent human tissues (reported in the legend
of Fig. 1) were immobilized. The amount of dotted RNAs was
normalized to the expression level of eight housekeeping genes
by the manufacturer, thus allowing determination of the rel-
ative expression level of a target mRNA in di¡erent tissues.
As shown in Fig. 1 strong hybridization signals were obtained
with liver and kidney RNA from both adult and fetal tissues
(Fig. 1, E 1,2 and G 3,4) using a radiolabeled 137 bp cDNA
fragment of C8Q. No other hybridization signal was detected
that was signi¢cantly above the background. Estimation of
the level of expression, as determined by phosphor imaging,
revealed that expression of C8Q in kidney was equivalent to
that in liver.
To test whether the renal C8Q is coexpressed with C8K or is
expressed independently, we performed PCR analysis using
primers speci¢c for C8K or C8Q. From Fig. 2 it is evident
that a C8Q PCR product, but no C8K product was obtained
from kidney RNA, whereas from liver RNA a product was
obtained for both of the genes. We also hybridized a Northern
blot containing RNA from several fetal tissues (brain, lung,
liver and kidney). With the C8Q probe a hybridization signal
was detected with liver and kidney RNA (Fig. 3A), whereas
with the C8K gene probe a signal was only seen with liver
RNA (Fig. 3B). Similar to the tissues from adult, quanti¢-
cation of the signal intensity on these blots indicated that
C8Q expression in fetal kidney is equivalent to that in fetal
liver.
Since it is known that within the lipocalins several members
of one speci¢c protein family could be encoded by di¡erent,
but very closely related genes [18,19], we cloned the entire
kidney-speci¢c C8Q transcript to perform sequence analysis.
Therefore, poly(A) RNA from human kidney was reverse-
transcribed and used as a template for PCR with oligonucleo-
tide primers derived from the 5P- and 3P-non-translated re-
gions of the C8Q cDNA. The resulting 709 bp DNA fragment
was ligated into a pGEM-T cloning vector and two positive
clones from independent PCR reactions were subjected to
DNA sequencing. The nucleotide sequence (data not shown)
of the cloned fragments was 100% identical to the liver-spe-
ci¢c C8Q cDNA sequence [1], thus indicating that C8Q from
liver and kidney are products of a single gene.
3.2. Prokaryotic overexpression of C8Q
Recently, human liver-speci¢c C8Q was expressed in insect
cells and COS-7 cells mainly to investigate the association
with other C8 factors and to study the function of C8Q in
context with complement action [7]. However, since our major
goal for producing a recombinant protein is to perform struc-
tural studies using NMR technology, which needs production
of large amounts of labeled protein, we decided to use E. coli
as an expression system. Although successful cytoplasmic pro-
duction of lipocalins in E. coli was reported [20,21], two as-
pects had to be considered: on the one hand, C8Q, as a com-
ponent of MAC, might be toxic for E. coli ; on the other hand,
FEBS 21696 15-3-99
Fig. 1. Human multiple tissue dot blot (Clontech) containing poly-
(A) RNAs from 50 di¡erent tissues immobilized in separate dots
was hybridized with a cDNA probe for human C8Q. Row A: 1,
whole brain; 2, amygdala; 3, caudate nucleus; 4, cerebellum; 5, cer-
ebral cortex; 6, frontal lobe; 7, hippocampus; 8, medulla oblongata.
Row B: 1, occipital lobe; 2, putamen; 3, substantia nigra; 4, tem-
poral lobe; 5, thalamus; 6, subthalamic nucleus; 7, spinal cord.
Row C: 1, heart; 2, aorta; 3, skeletal muscle; 4, colon; 5, bladder;
6, uterus; 7, prostate; 8, stomach. Row D: 1, testis; 2, ovary;
3, pancreas; 4, pituitary gland; 5, adrenal gland; 6, thyroid gland;
7, salivary gland; 8, mammary gland. Row E: 1, kidney; 2, liver;
3, small intestine; 4, spleen; 5, thymus; 6, peripheral leukocyte;
7, lymph node; 8, bone marrow. Row F: 1, appendix; 2, lung;
3, trachea; 4, placenta. Row G: 1, fetal brain; 2, fetal heart; 3, fe-
tal kidney; 4, fetal liver; 5, fetal spleen; 6, fetal thymus; 7, fetal
lung. Row H: 1, yeast total RNA 100 ng; 2, yeast tRNA 100 ng;
3, E. coli rRNA 100 ng; 4, E. coli DNA 100 ng; 5, poly(A)
100 ng; 6, human c0t1 DNA 100 ng; 7, human DNA 100 ng; 8, hu-
man DNA 500 ng.
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C8Q has an intramolecular disul¢de bond and a free Cys and
might therefore be incorrectly folded when expressed in the
cytoplasm. Therefore, we fused the E. coli OmpA signal pep-
tide encoding DNA to the DNA sequence encoding the ma-
ture C8Q (Fig. 4) in order to achieve periplasmic secretion.
Since the N-terminal amino acid residue of the native mature
C8Q could not be identi¢ed [1], we used an algorithm [22]
indicating Gln21 and Lys22 as most probable N-terminal ami-
no acids for the mature protein. For the recombinant C8Q we
chose Lys22 as the N-terminal amino acid because when fused
to the OmpA signal sequence this amino acid gives the most
preferential cleavage site in E. coli as calculated [22]. For
facile puri¢cation the recombinant protein was produced
with a 6UHis tag attached to the C-terminus. The OmpA-
C8Q fusion construct was cloned into a modi¢ed pQE vector
and transfected into E. coli strain M15. SDS-PAGE analysis
of cell extracts after induction of heterologous gene expression
by IPTG indicated the presence of an additional protein band
with an apparent Mr of 21 kDa (Fig. 5), which is in accord-
ance with that calculated from the deduced amino acid se-
quence. After puri¢cation by a⁄nity chromatography using
a Ni-NTA resin [23] and gel ¢ltration chromatography, the
protein was subjected to N-terminal amino acid sequence
analysis and the sequence found was KPQRPRRPAS, which
is identical to the deduced amino acid sequence. In addition,
this result demonstrated correct cleavage of the signal se-
quence. A preliminary characterization by SDS-PAGE, native
FEBS 21696 15-3-99
Fig. 3. Northern analysis of a human fetal multiple tissue blot.
Lane 1: fetal brain; lane 2: fetal lung; lane 3: fetal liver; lane 4:
fetal kidney; each lane contained approximately 2 Wg of poly(A)
RNA. A: Hybridized to a human C8Q cDNA probe. B: Hybridized
to a human C8K cDNA probe. For loading control the blot was
stripped and hybridized to a human GAPDH cDNA probe (lower).
Fig. 2. Agarose gel electrophoresis of PCR products. Lane 1: 100
bp DNA ladder; lane 2: kidney cDNA as template and C8Q
primers; lane 3: kidney cDNA template and C8K primers; lanes 4
and 5: same as lanes 2 and 3 but without reverse transcription;
lane 6: liver cDNA as template and C8Q primers; lane 7: liver
cDNA as template and C8K primers. 8 Wl of the PCR reaction was
applied to each lane.
Fig. 4. Construction of the OmpA-C8Q fusion for expression in E. coli and secretion into the periplasm. The E. coli OmpA signal peptide en-
coding DNA was chemically synthesized containing a SphI restriction site on the 5P-end and a blunt end at its 3P-end. In order to create the
SphI site and use the original start codon, the second codon AAA was mutated to CGA, resulting in an exchange of Lys for Arg. After SphI
cleavage this fragment was ligated to the 5P-blunt ended C8Q DNA fragment encoding the mature protein. Since the C8Q fragment contained a
3P-BamHI cleavage site the fused product was inserted into a SphI-BamHI-digested pQE-70 vector (Qiagen Inc., USA).
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gel electrophoresis and circular dichroism spectroscopy indi-
cated that the recombinant protein is homogeneous and seems
to be properly folded (data not shown).
4. Discussion
The data presented in this work demonstrate for the ¢rst
time that C8Q, which was so far characterized as an intrinsic
component of the terminal complement factor C8 in plasma,
is expressed in human kidney. Although some members of the
components of the classical and alternative activation path-
ways have been found to be synthesized in kidney [24,25], to
our knowledge this is, in general, the ¢rst clear evidence for
renal synthesis of a terminal complement component. The
C8Q-speci¢c mRNA synthesis in kidney is suggested to be
constitutive rather than induced, because we used RNA
from very di¡erent sources, including fetal RNA, and found
expression in all samples. Our experiments clearly demon-
strate that C8Q expression in kidney is independent of C8K,
since we could not detect C8K expression in human kidney
even when using the high sensitivity of PCR. Therefore, it is
clear that the biological function of C8Q is not restricted to a
speci¢c role in complement-mediated cell lysis in association
with C8 members, but is suggested to be more general. In this
context, it is interesting to note that C8Q does not seem to be
required for synthesis or function of C8K, nor is it essential
for the foundation and lytic activity of MAC; however, it
signi¢cantly enhances C8 hemolytic activity [7].
Based on sequence analysis, genomic structure and secon-
dary structure, C8Q is a member of the lipocalin protein family
[4,8]. Although binding of small lipophilic compounds, such
as retinol or retinoids, is a typical feature of several lipocalin
members [9^11], a speci¢c retinol binding activity could not be
observed with C8Q [7]. Nevertheless, additional binding studies
using other lipophilic ligands have to be performed. These
studies should include delipidation experiments, since endog-
enous ligands bound to the protein might disturb the binding
assays.
Our observation that C8Q is expressed in kidney could pro-
vide novel hints to the function of this protein. Consistent
with its expression in kidney and complex formation with
C8K, C8Q might exhibit protective action through scavenging
of potentially harmful lipophilic compounds, as suggested for
other lipocalin members [26]. Such harmful products could
accumulate in kidney as a direct result of the host defence
in response to microbial infection or the cellular release during
in£ammation. A protective function of C8Q might also be of
relevance in connection with C8 thereby reducing the in£am-
matory response when the MAC is deposited on host cell
membranes, thus allowing tissue recovery from immune at-
tack [3].
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Fig. 5. Production of recombinant C8Q in E. coli and puri¢cation of
the recombinant protein as analyzed by 0.1% SDS-14% PAGE.
Lane 1: Molecular weight markers. Lane 2: E. coli cell extract prior
to induction. Lanes 3 and 4: E. coli cell extracts after induction
with IPTG for 3 and 5 h. Lane 5: 5 Wg of recombinant protein
from periplasm after puri¢cation by Ni-NTA a⁄nity chromatogra-
phy. The gel was stained with Coomassie blue.
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